Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome.

Phase 1

• Conditions: metabolic syndrome treatment for diabet type II prevention; MedDRA version: 6.1Level: HLGTClassification code 10037008

• Registration Number: EUCTR2005-004639-24-IT
• Lead Sponsor: OSPEDALE S. RAFFAELE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-26
• Study Completion: 2009-06-30
• Last Update Posted: 26 October 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 294

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified